In primary rat hepatocytes, prolonged activation of the p42/44 mitogen-activated protein kinase (MAPK) pathway is associated with a decrease in DNA synthesis and increased expression of the cyclin-dependent kinase inhibitor (CKI) proteins p21Cip-1/WAF1 and p16INK4a. To evaluate the relative importance of these CKIs in mediating this response, we determined the impact of prolonged MAPK activation on DNA synthesis in primary cultures of hepatocytes derived from mice embryonically deleted (null) for either p21Cip-1/WAF1 or p16INK4a. When MAPK was activated in wild-type mouse hepatocytes for 24 h, via infection with a construct to express an inducible oestrogen receptor–Raf-1 fusion protein (ΔRaf:ER), the expression of p21Cip-1/WAF1 and p16INK4a CKI proteins increased, cyclin-dependent kinase 2 (cdk2) and cdk4 activities decreased, and DNA synthesis decreased. Inhibition of RhoA GTPase function increased the basal expression of p21Cip-1/WAF1 and p27Kip-1 but not p16INK4a, and enhanced the ability of MAPK signalling to decrease DNA synthesis. Ablation of the expression of CCAATT enhancer-binding protein α (C/EBPα), but not of the expression of C/EBPβ, decreased the ability of MAPK signalling to induce p21Cip-1/WAF1. When MAPK was activated in p16INK4a-null hepatocytes for 24 h, the expression of p21Cip-1/WAF1 increased, cdk2 and cdk4 activities decreased and DNA synthesis decreased. In contrast with these findings, prolonged activation of the MAPK pathway in hepatocytes from p21Cip-1/WAF1-null mice enhanced cdk2 and cdk4 activities and caused a large increase in DNA synthesis, despite elevated expression of p16INK4a. Inhibition of RhoA GTPase activity in p21Cip-1/WAF1-null cells partly blunted both the basal levels of DNA synthesis and the ability of prolonged MAPK signalling to increase DNA synthesis. Expression of anti-sense p21Cip-1/WAF1 in either wild-type or p16INK4a-null hepatocytes decreased the ability of prolonged MAPK signalling to increase the expression of p21Cip-1/WAF1, and permitted MAPK signalling to increase both cdk2 and cdk4 activities and DNA synthesis. These results argue that the ability of prolonged MAPK signalling to inhibit DNA synthesis in hepatocytes requires the expression of p21Cip-1/WAF1, and that the increased expression of p16INK4a has a smaller role in the ability of this stimulus to mediate growth arrest. Our results also suggest that RhoA function can modulate DNA synthesis in primary hepatocytes via the expression of p21Cip-1/WAF1 and p27Kip-1.
Skip Nav Destination
Follow us on Twitter @Biochem_Journal
Article navigation
December 1998
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
Research Article|
December 15 1998
Prolonged activation of the mitogen-activated protein kinase pathway promotes DNA synthesis in primary hepatocytes from p21Cip-1/WAF1-null mice, but not in hepatocytes from p16INK4a-null mice
Kelly L. AUER;
Kelly L. AUER
*Department of Radiation Oncology, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA 23298, U.S.A.
Search for other works by this author on:
Jong-Sung PARK;
Jong-Sung PARK
*Department of Radiation Oncology, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA 23298, U.S.A.
Search for other works by this author on:
Prem SETH;
Prem SETH
†Breast Cancer Section, Medicine Branch, National Cancer Institute, Building 10, Bethesda, MD 20892, U.S.A.
Search for other works by this author on:
Robert J. COFFEY;
Robert J. COFFEY
‡Department of Gastroenterology and Medical Oncology, Vanderbilt University, Nashville, TN 37232, U.S.A.
Search for other works by this author on:
Gretchen DARLINGTON;
Gretchen DARLINGTON
§Department of Pathology, Baylor College of Medicine, Houston, TX 77071, U.S.A.
Search for other works by this author on:
Arie ABO;
Arie ABO
‖Onyx Pharmaceuticals, 3031 Research Drive, Richmond, CA 94806, U.S.A.
Search for other works by this author on:
Martin McMAHON;
Martin McMAHON
¶Cancer Research Institute, University of California at San Francisco/Mount Zion Cancer Center, 2340 Sutter Street, S-329, San Francisco, CA 94115, U.S.A.
Search for other works by this author on:
Ronald A. DePINHO;
Ronald A. DePINHO
**Department of Adult Oncology, Dana–Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, U.S.A.
Search for other works by this author on:
Paul B. FISHER;
Paul B. FISHER
††Department of Urology and Pathology, Columbia University College of Physicians and Surgeons, 630 W 168th Street, New York, NY 10032, U.S.A.
Search for other works by this author on:
Paul DENT
Paul DENT
1
*Department of Radiation Oncology, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA 23298, U.S.A.
‡‡Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA 23298, U.S.A.
1To whom correspondence should be addressed (e-mail [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
June 23 1998
Revision Received:
August 14 1998
Accepted:
September 19 1998
Online ISSN: 1470-8728
Print ISSN: 0264-6021
The Biochemical Society, London © 1998
1998
Biochem J (1998) 336 (3): 551–560.
Article history
Received:
June 23 1998
Revision Received:
August 14 1998
Accepted:
September 19 1998
Citation
Kelly L. AUER, Jong-Sung PARK, Prem SETH, Robert J. COFFEY, Gretchen DARLINGTON, Arie ABO, Martin McMAHON, Ronald A. DePINHO, Paul B. FISHER, Paul DENT; Prolonged activation of the mitogen-activated protein kinase pathway promotes DNA synthesis in primary hepatocytes from p21Cip-1/WAF1-null mice, but not in hepatocytes from p16INK4a-null mice. Biochem J 15 December 1998; 336 (3): 551–560. doi: https://doi.org/10.1042/bj3360551
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Follow us on Twitter @Biochem_Journal
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() View past webinars > |